Josee Roy
36Patents
9h-index
21Co-inventors
71Inventor score
Filing activity: Apr 28, 2006 → Apr 3, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9198707B2 | Nerve and soft tissue ablation device and method | Human Necessities | 39 | Active |
| US9023023B2 | Nerve and soft tissue ablation device | Human Necessities | 15 | Active |
| US8623396B2 | Compositions and methods for delivering clonidine and bupivacaine to a target tissue site | Human Necessities | 13 | Active |
| US8916611B2 | Pharmaceutical removal of neuronal extensions from a degenerating disc | Chemistry; Metallurgy | 12 | Active |
| US7892724B2 | Method for enhancing the viability of mammalian cells, tissues and organs using a solution comprising two low molecular weight PEGs | Chemistry; Metallurgy | 12 | Active |
| US9610243B2 | Clonidine compounds in a biodegradable polymer | Human Necessities | 12 | Active |
| US7960098B2 | Methods and compositions for the preservation of cells and tissues | Human Necessities | 10 | Active |
| US8354221B2 | Methods and compositions for the preservation of cells and tissues | Human Necessities | 10 | Active |
| US9730986B2 | Pharmaceutical removal of neuronal extensions from a degenerating disc | Chemistry; Metallurgy | 9 | Active |
| US9789161B2 | Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin | Chemistry; Metallurgy | 9 | Active |
| US8927202B2 | Compositions for enhancing the viability of animal cells, tissues, and organ explants comprising two low molecular weight PEGs | Chemistry; Metallurgy | 9 | Active |
| US8153112B2 | Compositions and methods for treating cavity conditions | Human Necessities | 7 | Active |
| US9301946B2 | Clonidine and GABA compounds in a biodegradable polymer carrier | Human Necessities | 4 | Active |
| US8945623B2 | Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use | Human Necessities | 3 | Active |
| US9968572B2 | Clonidine and GABA compounds in a biodegradable polymer carrier | Human Necessities | 3 | Active |
| US9244060B2 | Site localization and methods for monitoring treatment of disturbed blood vessels | Physics | 2 | Active |
| US8840933B2 | Method of treating neuronal injury by administering magnesium chloride and PEG | Human Necessities | 2 | Active |
| US8545831B2 | Compositions and methods for treating a damaged cardiovascular element | Human Necessities | 2 | Active |
| US9078808B2 | Device to deliver magnesium in PEG formulation | Human Necessities | 2 | Active |
| US8858924B2 | Compositions and methods for treatment of hemorrhage | Human Necessities | 2 | Active |
| US8852566B2 | Compositions and methods for preferential distribution of active agents to injury sites | Human Necessities | 1 | Active |
| US8956667B2 | Methods of identifying potential components for targeted drug delivery compositions | Human Necessities | 1 | Active |
| US9950005B2 | Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use | Human Necessities | 0 | Active |
| USRE48948E1 | Clonidine compounds in a biodegradable polymer | General | 0 | Active |
| US9717756B2 | Method of treating traumatic brain or spinal cord injury with biomembrane sealing agent and magnesium compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.